AbbVie Inc (4AB.SG)
Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
As of 08:09AM CEST. Market open.
| Previous Close | 144.16 |
| Open | 144.04 |
| Bid | 144.12 x 100000 |
| Ask | 144.52 x 100000 |
| Day's Range | 144.04 - 144.04 |
| 52 Week Range | 119.10 - 167.54 |
| Volume | |
| Avg. Volume | 123 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | Jul 25, 2024 - Jul 29, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PR NewswireAbbVie Completes Acquisition of Landos Biopharma
AbbVie (NYSE: ABBV) announced today that it has completed its acquisition of Landos Biopharma, Inc. (NASDAQ: LABP). With the completion of the acquisition, Landos is now part of AbbVie.
ZacksWhy AbbVie (ABBV) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
ZacksLilly (LLY) Hits Record High on Crohn's Disease Study Data
Eli Lilly's (LLY) stock hits an all-time high after announcing detailed results from a late-stage study on mirikizumab in Crohn's disease.
© 2024 Yahoo. All rights reserved.